3 results match your criteria: "Institute for Research and Innovation in Biomedicine of Normandy (IRIB) Rouen[Affiliation]"

Coronaridine congeners induce anticonvulsant activity in rodents by hippocampal mechanisms involving mainly potentiation of GABA receptors.

Eur J Pharmacol

November 2024

Department of Medical Biochemistry, Rouen University Hospital, CHU de Rouen, France; Laboratory of Neuroendocrine, Endocrine and Germinal Differentiation and Communication (NorDiC), Inserm UMR 1239, University Rouen Normandie, 76000 Rouen, France; Normandie University, UNIROUEN, Institute for Research and Innovation in Biomedicine of Normandy (IRIB) Rouen, France. Electronic address:

Article Synopsis
  • The study investigates the anticonvulsant effects of coronaridine congeners, catharanthine and 18-MC, on male and female mice, revealing that both compounds show acute anticonvulsant activity independent of sex.
  • Repeated treatment with a low dose of these congeners increased their anticonvulsant effectiveness more in males than in females, indicating a gender difference in response.
  • The mechanisms involved include GABA receptor (GABAR) potentiation in the hippocampus, with less influence from monoamines like dopamine and serotonin.
View Article and Find Full Text PDF

Coronaridine congeners induce sedative and anxiolytic-like activity in naïve and stressed/anxious mice by allosteric mechanisms involving increased GABA receptor affinity for GABA.

Eur J Pharmacol

August 2023

Department of Medical Biochemistry, Rouen University Hospital, CHU de Rouen, France; Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Normandie University, UNIROUEN, INSERM U1239, Institute for Research and Innovation in Biomedicine of Normandy (IRIB) Rouen, France. Electronic address:

The sedative and anxiolytic-like activity of two coronaridine congeners, (+)-catharanthine and (-)-18-methoxycoronaridine (18-MC), was studied in male and female mice. The underlying molecular mechanism was subsequently determined by fluorescence imaging and radioligand binding experiments. The loss of righting reflex and locomotor activity results showed that both (+)-catharanthine and (-)-18-MC induce sedative effects at doses of 63 and 72 mg/kg in a sex-independent manner.

View Article and Find Full Text PDF

Coronaridine congeners potentiate GABA receptors and induce sedative activity in mice in a benzodiazepine-insensitive manner.

Prog Neuropsychopharmacol Biol Psychiatry

July 2020

Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Normandie University, UNIROUEN, INSERM U1239, Institute for Research and Innovation in Biomedicine of Normandy (IRIB) Rouen, France; Department of Medical Biochemistry, Rouen University Hospital, CHU de Rouen, France. Electronic address:

To determine whether (+)-catharanthine induces sedative- or anxiolytic/anxiogenic-like activity in male mice, proper animal paradigms were used. The results showed that (+)-catharanthine induces sedative-like activity in the 63-72 mg/Kg dose range in a flumazenil-insensitive manner, but neither this effect nor anxiolytic/anxiogenic-like activity was observed at lower doses. To determine the underlying molecular mechanism of the sedative-like activity, electrophysiological and radioligand binding experiments were performed with (+)-catharanthine and (±)-18-methoxycoronaridine [(±)-18-MC] on GABA (GABARs) and glycine receptors (GlyRs).

View Article and Find Full Text PDF